← Leaderboards
Sandra Ann Rempel
Henry Ford Health System
$3,374,829
Attributed
$3,374,829
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $304.6K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$3,374,829 · 3
By mechanism
R01$3,263,354 · 2
R21$111,475 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry Ford Health System
Same institution · by research overlap
- Shulin Li$17,068,216
- Zheng Gang Zhang$14,094,277
- Xiao-Ping Yang$6,327,825
- Ali Syed Arbab$5,335,491
- Pamela Harding$4,117,096
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaCysteineNeoplastic CellExtracellular MatrixTumorCellsTumor Cell InvasionNeoplasm /Cancer InvasivenessTherapeutic TargetIn VitroIn VivoMigrationCell LineProteinsHspb1 GeneHuman TissueIntegrin Beta ChainsCell ProliferationAstrocytesGlioblastomaActinsBehaviorCell MigrationCytoskeleton
Grant awards (14)
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.$299,552
R01 · FY2015 · CA · contact PI
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.$290,565
R01 · FY2014 · CA · contact PI
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.$175,749
R01 · FY2013 · CA · contact PI
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.$113,311
R01 · FY2013 · CA · contact PI
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.$303,988
R01 · FY2012 · CA · contact PI
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.$303,988
R01 · FY2011 · CA · contact PI
THE ROLE OF SPARC IN GLIOMA INVASION$245,769
R01 · FY2007 · CA · contact PI
THE ROLE OF SPARC IN GLIOMA INVASION$253,109
R01 · FY2006 · CA · contact PI
THE ROLE OF SPARC IN GLIOMA INVASION$304,648
R01 · FY2005 · CA
THE ROLE OF SPARC IN GLIOMA INVASION$259,200
R01 · FY2004 · CA
ROLE OF SPARC IN GLIOMA INVASION$238,166
R01 · FY2003 · CA
ROLE OF SPARC IN GLIOMA INVASION$238,166
R01 · FY2002 · CA
ROLE OF SPARC IN GLIOMA INVASION$237,143
R01 · FY2001 · CA
SPARC--A DIAGNOSTIC MARKER FOR INVASIVE MENINGIOMA$111,475
R21 · FY2000 · CA